10th week of 2016 patent applcation highlights part 7 |
Patent application number | Title | Published |
20160067101 | CLIP-ON EARMUFF AND KIT - The present invention is an earmuff including first and second muff portions with a clip disposed between them. The clip is manipulatable into closed and open positions. When the clip is open, the upper sections of the first and second muff portions are separated. When the clip is closed, the upper sections are together. The earmuffs are designed to cover a human ear and are to be clipped to the headband of a cap by putting the earmuff into the open position, positioning the earmuff around the headband, and positioning the earmuff into the closed position. | 2016-03-10 |
20160067102 | WOUND DRESSINGS - A wound dressing comprises an absorbent body of foam material with first and second major surfaces. The first major surface is, in use, the wound-facing surface of the absorbent body. A thermochromic indicator is incorporated into, or is in intimate contact with, the second major surface of the absorbent body. The thermochromic indicator is sensitive to a change in temperature of the skin below the dressing and so is indicative of an infection. | 2016-03-10 |
20160067103 | THERMOPLASTIC SHEET FOR MOLDING A MASK ON A PERSON'S BODY - The present invention provides a thermoplastic sheet material for skin cosmetic treatment and/or skin medical treatment, comprising a thermoplastic composition layer having an upper surface and a lower surface; and a support layer bonded on at least one surface of the thermoplastic composition layer, wherein said support layer comprises silicone. | 2016-03-10 |
20160067104 | WOUND CARE DEVICES, APPARATUS, AND TREATMENT METHODS - A wound care device for delivering topical oxygen therapy, negative pressure wound therapy, and a low intensity vacuum therapy for treatment of a wound. The wound care device may include an oxygen supply MEA, an oxygen consuming MEA, a vacuum pump and motor, a pressure sensor, and a power supply and electronic controls. A dressing may be connected to the wound care device for administering topical continuous oxygen therapy and simultaneous negative pressure wound therapy to a wound. A canister or exudate trap may be positioned between the dressing and the vacuum supply port of the vacuum pump to collect and store exudates from the wound. The canister may be combined with the dressing. | 2016-03-10 |
20160067105 | SYSTEM, METHOD, AND PRODUCT FOR AN ADHESIVE STRIP CONFIGURED TO SELECTIVELY DISPENSE A FLUID - A fluid dispensing adhesive strip is presented. The fluid dispensing adhesive strip includes a backing layer having a first side and a second side, an adhesive that is disposed on at least a portion of the second side of the backing layer, and a packet that is disposed on the backing layer that includes a dispensable fluid and an activation mechanism that permits selective dispensing of the dispensable fluid. The packet can include multiple chambers configured to contain the same or different fluids, and channels associated with the chambers for dispensing the fluid when the activation mechanism is activated. The activation mechanism can be a tear-away strip, and can include perforations, serrations, and scoring to facilitate activation. Release strips in communication with the adhesive can releasably detach from the adhesive enabling the fluid dispensing strip to be applied and secured to an object or person. | 2016-03-10 |
20160067106 | Protective Dressing For Skin-Placed Medical Device - A dressing for use in protectively covering and isolating a medical device placed on and/or through the skin surface of a patient is disclosed. Examples of such devices include infusion needles for accessing subcutaneously implanted access ports, catheters of various types and purposes, insulin infusion needles, etc. In one embodiment, a dressing for covering a medical device on a skin surface of a patient is disclosed and comprises a dressing portion that is configured to rest against a skin surface of a patient, with the dressing portion defining a hole, and a polymeric cover film that is at least indirectly attached to the dressing portion. The cover film includes a pliable domed portion aligned with the hole of the dressing portion. The pliable domed portion defines a cavity that is configured to receive therein the medical device when the dressing is placed on the skin of the patient. | 2016-03-10 |
20160067107 | ABSORBENT WOUND DRESSINGS - An absorbent wound dressing ( | 2016-03-10 |
20160067108 | SOLE STIMULATION SOCK - There is provided a sole stimulation sock, in which an inner side of a sole portion between a heel portion and a toe portion is formed with projected portions and recessed portions, in which a proportion of an area of the projected portions, with respect to the sum of the areas of the projected portions and the recessed portions, is 26% to 68%, in which the difference between a proportion of an area of the projected portions in any one division region of four division regions of the inner side of the sole portion and a proportion of an area of the projected portions in other division regions is less than or equal to 30%, in which the average value of the areas of the projected portions is 7 mm | 2016-03-10 |
20160067109 | CONFORMABLE THERAPEUTIC SHIELD FOR VISION AND PAIN - A conformable covering comprises an outer portion with rigidity to resist movement on the cornea and an inner portion to contact the cornea and provide an environment for epithelial regeneration. The inner portion of the covering can be configured in many ways so as to conform at least partially to an ablated stromal surface so as to correct vision. The conformable inner portion may have at least some rigidity so as to smooth the epithelium such that the epithelium regenerates rapidly and is guided with the covering so as to form a smooth layer for vision. The inner portion may comprise an amount of rigidity within a range from about 1×10-4 Pa*m3 to about 5×10-4 Pa*m3 so as to deflect and conform at least partially to the ablated cornea and smooth an inner portion of the ablation with an amount of pressure when deflected. | 2016-03-10 |
20160067110 | ABSORBENT-ARTICLE SHEET MEMBER MANUFACTURING APPARATUS - An absorbent sheet manufacturing apparatus has a particle collision surface ( | 2016-03-10 |
20160067111 | APPARATUSES FOR TRANSFERRING DISCRETE ARTICLES - The present disclosure is directed to a transfer assembly for transferring discrete articles from or to a moving carrier member. The transfer assembly comprises a frame defining a rotation axis. The frame comprises a track having a circumferential shape surrounding the rotation axis. The transfer assembly comprises transfer members movably engaged with the track, each having a transfer surface. The transfer assembly comprises a wheel engaged with the frame and configured to rotate about the rotation axis. The wheel is engaged with the transfer members. As the wheel rotates about the rotation axis, the transfer members circumnavigate about a path about the rotation axis in correspondence with the track. The shape of the track causes the transfer surfaces to move radially relative to the rotation axis while the transfer surfaces are maintained a substantially constant distance away from the moving carrier member at the point of discrete article transfer. | 2016-03-10 |
20160067112 | Absorbent Article Having A Wetness Indicator - An absorbent article having an outer cover with an interior surface and an opposite exterior surface, an absorbent core positioned adjacent the interior surface of the outer cover, and a wetness indicator graphic located on the outer cover. The wetness indicator graphic has a permanent graphic defining at least one non-printed area and a changing graphic located within the at least one non-printed area of the permanent graphic such that the permanent graphic and the changing graphic together give the appearance of a uniform graphic. | 2016-03-10 |
20160067113 | ELECTRONICS ENCLOSURE AND RECEPTACLE - An electronics enclosure has terminal conductors for contacting corresponding conductors in a receptacle when engaged with the receptacle. The electronics enclosure has a housing having first, second, third, fourth, fifth and sixth surface portions arranged to define the exterior of the housing. The receptacle engages and retains the corresponding electronics enclosure, the receptacle having terminal conductors for contacting corresponding conductors in the enclosure when engaged with the enclosure. The receptacle has a base surface along which the enclosure can translate in an engagement direction to engage the enclosure with the receptacle. An absorbent article management system includes: a diaper having the receptacle at which sensor elements of the diaper terminate; a logger unit having logger electronics enclosed in the enclosure and adapted to cooperate with the receptacle to connect the logger electronics to the sensor elements; and data processing equipment for processing data acquired from the sensor elements by the logger and for taking action based on the same. | 2016-03-10 |
20160067114 | ABSORBENT ARTICLES COMPRISING WETNESS INDICATORS - An absorbent article of the present invention may comprise a backsheet, a wetness indicator composition, and an absorbent core. The wetness indicator composition may comprise a stabilizer, a colorant, and a matrix. The absorbent core may comprise a nonwoven layer and an absorbent polymer material, and optionally, a thermoplastic adhesive material. The wetness indicator composition may be in direct contact with an inner surface of the backsheet and an outer surface of the nonwoven layer. And, the absorbent polymer material, and optionally, the thermoplastic adhesive material, may be in direct contact with an inner surface of the nonwoven. Further, the absorbent core may be substantially cellulose free and may be oriented in at least one row. | 2016-03-10 |
20160067115 | ELASTIC STRUCTURE FOR ABSORBENT ARTICLE AND METHOD FOR MANUFACTURING ELASTIC STRUCTURE FOR ABSORBENT ARTICLE - An object of the present invention is to provide an elastic structure that has straightly extended ridges with excellent appearance, air permeability, and fluffy feel. The object can be attained by an elastic structure in which a first sheet material ( | 2016-03-10 |
20160067116 | DISPOSABLE GARMENT - This invention claims disposable garments comprising a stretchy laminate and methods of making the same. | 2016-03-10 |
20160067117 | DISPOSABLE ARTICLE INCLUDING AT LEAST ONE ELASTIC BONDED REGION - This invention claims a disposable article including at least two bonded regions, one of the regions has elastic properties; the other region is different from the first. | 2016-03-10 |
20160067118 | Nonwoven Web - Nonwoven webs for use in absorbent articles are disclosed. A nonwoven web can have a first nonwoven layer and a second nonwoven layer. The first nonwoven layer has a first plurality of fibers, a first side and a second side opposed to the first side, and a first plurality of apertures extending through the first nonwoven layer from the first side to the second side. The first nonwoven layer also has an additive which is disposed, at least in part, on at least a portion of the first plurality of fibers. The second nonwoven layer has a second plurality of fibers, a first side and a second side opposed to the first side. The second nonwoven layer is attached to the first nonwoven layer such that at least a portion of the second plurality of fibers is in liquid communication with the first plurality of apertures. | 2016-03-10 |
20160067119 | ABSORBENT PRODUCTS HAVING IMPROVED PACKAGING EFFICIENCY - A package comprising an interior space and an exterior surface may have a plurality of disposable absorbent articles disposed within the interior space of the package. Each of the disposable absorbent articles may have a topsheet; a backsheet; a substantially cellulose free absorbent core located between the topsheet and the backsheet. The absorbent products may exhibit an In-Bag Stack Height of less about 80 mm as measured according to an In-Bag Stack Height Test. | 2016-03-10 |
20160067120 | ABSORBENT ARTICLES AND METHODS AND SYSTEMS OF PACKAGING THEM - Certain configurations of articles comprising stacked layers of absorbent articles are described herein. In certain examples, the absorbent articles of a particular layer are arranged in two or more lanes. In some instances, adjacent stacks of the stacked layers are separated by a divider configured to provide support to at least one lane of absorbent articles of a first stack. Systems and methods of producing and packaging the articles are also described. | 2016-03-10 |
20160067121 | LIFT APPARATUS FOR A VEHICLE - A lift apparatus ( | 2016-03-10 |
20160067122 | WHEELCHAIR CURB-CLIMBING AND CURB-DESCENDING SYSTEM - A wheelchair curb-climbing and curb-descending system for aiding a wheelchair to negotiate a curb. The system includes a wheelchair attachment mechanism; a pair of front arms adapted to extend to lift a front portion of wheelchair and to retract back to lower the front portion of the wheelchair; a pair of rear arms adapted to extend to lift a rear portion of wheelchair and to retract back to lower the rear portion of the wheelchair. The system further includes an arm extending mechanism for extending/retracting the arms; a rotatable lifting-arm wheel at free ends of each arm; a wheel motor for rotating the arm wheels; an operation control unit; and a leveling mechanism for ensuring the seat of the wheelchair remains substantially level to the ground during operation of the system. | 2016-03-10 |
20160067123 | SYSTEM AND METHOD FOR PREVENTING FALL-RELATED INJURIES - A system for preventing fall-related injuries is described. The system comprises a re-useable airbag which can be mounted on a wheelchair, power chair, stroller or scooter or can be design as a hip protector to be put on a waist of a wearer. The system further comprises a fall detection unit that can automatically trigger inflation of the airbag system in case of a fall. | 2016-03-10 |
20160067124 | SUPPORT PLATFORM FOR SEATED APPLIANCE - A support arrangement and corresponding method, is provided for supporting a user in a seated invalid appliance, the arrangement comprising a support member and at least one reconfigurable connection arrangement arranged to enable connection of the support member to the appliance and the application an adjustable tensile load to the support member. The connection arrangement may comprise a bridging element configured to extend between the support member and the appliance, such as a clip or hook. The hook or clip may be S-shaped or C-shaped in cross section. The connection arrangement may be received in an aperture or recess provided in the support member and/or the appliance to bridge the gap there between. The invention is particularly suited for use with wheelchairs or seated sports appliances for a disabled user. | 2016-03-10 |
20160067125 | SEAT ASSIST DEVICE - A seat assist device is described. The seat assist device includes a base, a lift platform having a front portion and a rear portion, with the front portion of the lift platform being pivotally connected with the base. A lifting arm is connected with the rear portion of the lift platform. The lifting arm extends from the lift platform to project beyond the front potion of the lift platform, with the lifting arm terminating in handles for grasping by a user. A lift bar is pivotally connected between the base and the lifting arm, whereby a user sitting upon the seat assist device can press downward on the handles to cause the rear portion of the lift platform to rise and, in doing so, assist the user in rising from a seated position. | 2016-03-10 |
20160067126 | SYSTEM AND METHOD FOR OFF-LOADING OF THE BODY IN THE PRONE POSITION AND FOR PATIENT TURNING AND REPOSITIONING - The present invention relates to a system and method for support and off-loading. The system includes an inner bladder filled with a flowable composition. An outer bladder filled with a flowable composition is positioned adjacent to the inner bladder. The composition of the inner bladder has greater flow characteristics than the composition of the outer bladder. The inner bladder micro-contours to the received body part and the outer bladder macro-contours to the inner bladder after the inner bladder is micro-contoured to the received body part. Alternatively, the system provides a pair of ultra low pressure plenums and a positioner. The patient body size and size and corresponding surface area of the positioner control the amount of gas which is displaced evenly against the walls of the ultra low pressure plenums. | 2016-03-10 |
20160067127 | BED APPARATUS - A bed apparatus including, at least, two drivers or a first driver and a second driver, the first driver being in linkage with the second driver, comprises: a calculating means for calculating a calculated bed state value, based on the first driver and the second driver; an error detecting means for detecting error between the calculated bed state value and a designated bed state value designated by the user; and, an error correcting means for correcting the detected error when an error is detected by the error detecting means. As a result, it is possible to provide a bed apparatus that can coincide the designated state of the bed apparatus with the actual state of the bed apparatus by appropriately correcting the error between the drivers. | 2016-03-10 |
20160067128 | CUSHIONING DEVICE AND METHOD - Disclosed herein is a cushioning device that includes a first foam layer including a first top surface and a first bottom surface, the first foam layer including a plurality of first channels located in the first top surface. Further disclosed is a support fluid cell located in each of the plurality of first channels. Moreover, a second foam layer including a second top surface and a second bottom surface is disclosed, the second foam layer including a second channel located in the second top surface. The cushioning device includes a counterbalance fluid cell located in the second channel. The second foam layer is located underneath the first foam layer. The first foam layer, in combination with the support fluid cells, create a support surface configured to support a load of a person. | 2016-03-10 |
20160067129 | LIMB POSITIONER - The invention features a kit comprising components for a device for positioning and supporting a limb (e.g., an arm or leg) of a patient. The invention also features methods of assembling and adjusting a limb positioning device. | 2016-03-10 |
20160067130 | METHOD AND APPARATUS FOR MOVING A HOSPITAL BED OR ANOTHER WHEELED OBJECT - A wheeled object, such as a bed ( | 2016-03-10 |
20160067131 | PATIENT REPOSITIONING SYSTEM - A patient repositioning system for pulling a patient toward a head end of a bed includes a sheet, a mattress, and a housing which contains at least a part of a drive mechanism for operatively coupling to and pulling the sheet. The housing resides below a head end piece of the mattress, and is secured to the bed deck. The sheet pulling structure extends out of the housing via a slot and releasably attaches to the sheet, in a manner which has a low profile so as to pass through the slot. The sheet is longer than and wider than the mattress, and has beaded longitudinal side edges which are retained within rows of spaced retainers located on opposite sides of the mattress. During pulling of the sheet, the contoured shape of the housing facilitates movement of the sheet into the housing via the slot, even though the sheet width extends beyond the lateral edges of the mattress. The sheet may include indicia for indicating a “loaded” condition, and also usage indicia to indicate that it is time for a new sheet to be used. | 2016-03-10 |
20160067133 | METHOD AND CHAMBER FOR EXPOSURE TO NON-ALLERGIC RHINITIS TRIGGER ENVIRONMENTS - The present invention is a method and chamber for exposure of human subjects to non-allergic rhinitis (“NAR”) trigger environments. The method occurs in a NAR chamber and involves tests that expose subjects to environmental triggers known to induce NAR symptoms. The chamber may be an enclosure capable of housing multiple subjects, constructed to facilitate the NAR tests and/or challenges and operable to create one or more NAR environments within the chamber. A different NAR environment may be required for each test. The chamber may facilitate the creation and containment of a specific NAR environment relating to a NAR test and/or challenge within the chamber for a particular period of time and achieve air-flow therein whereby subjects positioned within the chamber may be exposed to a NAR trigger environment in a virtually consistent manner. NAR tests and challenges may be assessed and the results thereof may be stored, compiled and/or reported. | 2016-03-10 |
20160067134 | REMOTE CONTROL HOUSING SYSTEMS, DEVICES, AND METHODS, AND PROTECTIVE COVERS FOR REMOTE CONTROLS - A cover device for a remote control device comprises an anterior wall defining a central opening therein, a posterior wall formed of two ledges and defining a gap therein, a first lateral wall connected to the anterior wall and the posterior wall, a second lateral wall connected to the anterior wall and the posterior wall, a superior wall connected to the anterior wall, the posterior wall, the first lateral wall, and the second lateral wall, and a door hingedly connected to the anterior wall. The cover device may further comprise two overhangs connected to one of the lateral walls, and the two overhangs may define a rail slot. The cover device may be slidably attachable to a side rail of a surgical table via the rail slot. A remote control device is slidably insertable into the remote control cover device. | 2016-03-10 |
20160067135 | METHOD OF SECURING A PATIENT ONTO AN OPERATING TABLE WHEN THE PATIENT IS IN THE TRENDELENBURG POSITION AND APPARATUS THEREFOR INCLUDING A KIT - A method of securing a patient onto an operating table when the patient is in the Trendelenburg position and apparatus therefor including a kit. A viscoelastic pad is used to support and hold a patient on a medical procedure table during a medical procedure performed while the table, and thus the patient lying thereon, is in an inclined position, such as the Trendelenburg position. The viscoelastic pad has characteristics which promote a minimization of pressure forces on the patient's body, as well as promote a secure cushioning and holding of the patient in a desired position on the table, in order to minimize injury to the patient. | 2016-03-10 |
20160067136 | GAME-BASED SENSORIMOTOR REHABILITATOR - Treatment of neurological injury through motor relearning. A game-based sensorimotor rehabilitator that enables individuals to interact with the functional objects using the appropriate amount of force, tilt, finger movement, and muscle activity to regain lost skill due to injury. | 2016-03-10 |
20160067137 | SELF CONTAINED POWERED EXOSKELETON WALKER FOR A DISABLED USER - A walker for use by a mobility impaired disabled user. The walker supports the user while moving them through a set of movements correlating to a walking motion. The walker includes an exoskeleton, a power source in the form of a battery pack or other similar onboard power pack together with its associated power supply cables, and a control system | 2016-03-10 |
20160067138 | SYSTEM FOR PERCUTANEOUSLY ADMINISTERING REDUCED PRESSURE TREATMENT USING BALLOON DISSECTION - A reduced pressure delivery system for applying reduced pressure tissue treatment to a tissue site is provided. The system includes a manifold delivery tube and a balloon having an inner space. The balloon is capable of assuming collapsed and expanded positions. The system further includes a manifold having a plurality of flow channels. The manifold is disposed within the inner space of the balloon. A sharp tip is configured to be delivered within the manifold delivery tube to puncture the balloon. | 2016-03-10 |
20160067139 | Shock Wave Electrodes with Fluid Holes - Medical devices utilizing shock waves with spark gap electrodes that include fluid holes into the respective electrode cores. | 2016-03-10 |
20160067140 | CPR CHEST COMPRESSION MACHINE STOPPING TO DETECT PATIENT RECOVERY - Embodiments of the present concept are directed to CPR chest compression machines that include a sensor to detect a parameter about a patient, such as an indication of patient recovery, and include a processor that determines whether to cease series of successive compressions on the patient in response to the detected parameter. | 2016-03-10 |
20160067141 | MEDICAL APPARATUS COMMUNICATION SYSTEM AND MEDICAL APPARATUS - A medical apparatus communication system includes a first medical apparatus and a second medical apparatus. The first medical apparatus includes a first communicating unit which establishes a communication connection with the second medical apparatus to communicate with the second medical apparatus, and a first controlling unit which controls the first medical apparatus. The second medical apparatus includes a second communicating unit which establishes a communication connection with the first medical apparatus to communicate with the first medical apparatus, a second controlling unit which controls the second medical apparatus, and a second sound outputting unit which performs a sound output in accordance with a control of the second controlling unit. The second controlling unit controls the sound output of the second sound outputting unit in a predetermined timing after establishment of the communication connection between the first and second communicating units. | 2016-03-10 |
20160067142 | STORAGE OR INFUSION BOTTLE - The present invention relates to a storage or infusion bottle ( | 2016-03-10 |
20160067143 | SYSTEM FOR FACILITATING PREPARATION OF MEDICATION DOSES - Delivery cups may be provided to facilitate preparation of medication doses and may include color bands extending about at least a portion of an exterior of each delivery cup. Each color band may correspond to a predetermined volumetric measurement or dosage of medication. Each delivery cup may provide a height that may be proportional to at least one of a maximum volume and a maximum volumetric measurement. Further, each delivery cup may provide one or more additional color bands that may represent volumetric measurements that may be less than that associated with the first color band. Each delivery cup may further provide a portion of the delivery cup that may be provided to fit inside of a medicine bottle and may be provided to a seal an opening of the medicine bottle. Each delivery cup may also provide a handle for dispensing fluid from the delivery cup. | 2016-03-10 |
20160067144 | Solution Delivery Device and Method - The present specification discloses a solution delivery device having a container component and a plug component configured for selective engagement with the container component. The container component has an internal cavity including an elongated mixing channel containing a first constituent, and the plug component provides an internal flow path configured for introduction of a second constituent into the mixing channel for mixing with the first constituent. The plug component may be inserted within the container component partially in a first operational mode and fully in a second operational mode. The first constituent may be a drug and the second constituent a diluent, such that the drug may be lyophilized with the device in the first operational mode and reconstituted with the device in the second operational mode. Multiple devices may be employed in tandem for the co-delivery of multiple constituents. The device may be included in a kit or installed within an injector. | 2016-03-10 |
20160067145 | MEDICINE CUP WITH INFECTION CONTROL TAB - A medicine cup, preferably stackable, disposable, of frustoconical configuration and optionally biodegradable. The medicine cup includes a cup member for the medicine and an infection control tab coupled to the cup member. The tab is preferably coplanar with and integrally mounted to the sidewall of the cup member and has a textured frictional surface. The infection control tab is for holding the cup by the health care provider, the tab minimizing the possibility of contamination of the cup and patient through the health care provider's hands. | 2016-03-10 |
20160067146 | MULTIFUNCTIONAL FEEDING-BOTTLE - The present patent application discloses a multifunctional feeding-bottle, including an outer cup, a liner, a nipple assembly connected to an opening of the outer cup, and a bottom cover connected to the bottom of the outer cup. The feeding-bottle further includes a valve piece disposed between the bottom of the outer cup and the bottom cover. An air inlet is disposed in a central part of a body of the valve piece. A stiffener is disposed at a part other than the air inlet. A cavity is formed between one side of the valve piece provided with the stiffener and the bottom cover. A sealing protrusion capable of sealing the air inlet is disposed at a central part of the bottom cover. An air vent is disposed at a part different from the sealing protrusion. The liner is disposed in the outer cup, and is configured to be removed from the outer cup. | 2016-03-10 |
20160067147 | TRANSFER LID - A transfer lid for a fluid container, having an attachment collar for removably attaching the transfer lid to the fluid container, and an inner collar arranged generally concentrically with and spaced inwardly from the attachment collar, the inner collar having a vent opening such as a vent slot extending therethrough. | 2016-03-10 |
20160067148 | GASTRIC SYSTEMS, APPARATUS, AND METHODS FOR USE WITH ENTERAL FEEDING - Systems, methods, and apparatus for gastric pressure relief, flow regulation, location, gastric residual volume, a placement reminder, bidirectional fluid flow markings, reintroducing gastric material, collection reservoir raising, collection reservoir hanging, a drain port, setting tube length, and vent membranes. A gastric pressure relief system is used in connection with an enteral feeding system, which includes a feeding container, administration tubing and a delivery tube, where the gastric pressure relief system is interposed between the administration tubing and the delivery tube. The gastric pressure relief system includes a collection reservoir with a gas vent to ambient atmosphere, relief tubing secured to both the collection reservoir and a multi-way connector. The multi-way connector joins the administration tubing to the relief tubing and a delivery tube at a point below a patient's stomach, which is designated on a placement reminder apparatus. | 2016-03-10 |
20160067149 | PHOTO-CHEMICALLY ACTIVATED MICRO-BUBBLE BASED ROOT CANAL DISINFECTION - A photo-chemically activated micro-bubble based root canal disinfection method for disinfecting a shaped root canal comprises (a) introducing a photoactive solution into the root canal, the photoactive solution containing a photoactive compound (such as methylene blue) dissolved in an alcohol carrier solution (such as polyethylene glycol and/or ethanol); (b) removing excess photoactive solution from the root canal; (c) introducing a micro-bubble solution comprised of an oxygen carrier (such as perfluorocarbon), an oxidizing agent (such as hydrogen peroxide) and a surfactant (such as a nonionic polyoxyethylene surfactant); (d) sonically or ultrasonically activating the micro-bubble solution in the canal; and (e) introducing light into the canal. | 2016-03-10 |
20160067150 | SUNSCREEN SHEET - The present disclosure relates to a cosmetic or dermatological sheet impregnated with a sunscreen fluid cosmetic composition. Specifically, the present disclosure relates to a cosmetic or dermatological sheet impregnated with a sunscreen fluid cosmetic composition and method to apply sunscreen to the human user's back or entire body. The sheet may have stitching and other composition or structural aspects to increase the structural integrity, hand slits, mitts or finger holes in the fabric, and/or areas that are not impregnated with a sunscreen composition to enable the user to more easily or tightly grasp the sheet during application of the sunscreen composition. Additionally, the sheet may be used to apply sunscreen to the user's back or entire body more than once before discarding the sheet and may include or consist of dyes, paints, tints or emboss to change the color or design of the sheet. | 2016-03-10 |
20160067151 | DERMATOLOGICAL SHEET HAVING A COMPOSITION IMPREGNATED THEREIN - The present disclosure relates to a cosmetic or dermatological sheet impregnated with a sunscreen fluid cosmetic composition. Specifically, the present disclosure relates to a cosmetic or dermatological sheet impregnated with a sunscreen fluid cosmetic composition and method to apply sunscreen to the human user's back or entire body. The sheet may have stitching and other composition or structural aspects to increase the structural integrity, hand slits, mitts or finger holes in the fabric, and/or areas that are not impregnated with a sunscreen composition to enable the user to more easily or tightly grasp the sheet during application of the sunscreen composition. Additionally, the sheet may be used to apply sunscreen to the user's back or entire body more than once before discarding the sheet and may include or consist of dyes, paints, tints or emboss to change the color or design of the sheet. | 2016-03-10 |
20160067152 | COSMETIC FACIAL AND BODY PEEL - The invention relates to cosmetic cleaning agents, which contain a) polylactic acid particles and b) at least one additional organic or inorganic, water-insoluble abrasive component that is different from a) and has absolute particle sizes in the range of 40 to 500 μm. Regular use of the cleaning agent leads to improvement of the complexion, in particular to pore refinement in the face, back, and cleavage region, and/or to matting the skin. | 2016-03-10 |
20160067153 | Translucent gel system - The present invention concerns a translucent gel system, notably a hair conditioner gel, comprising at least a carboxylic acid, an alkoxylated alkyl or alkenyl amine and a cationic surfactant. Such a translucent gel system provides an excellent conditioning effect for washing skin and/or hair and a high transmittance. | 2016-03-10 |
20160067154 | LIQUID PERSONAL CLEANSING COMPOSITION - A stable, multiphase liquid isotropic cleansing composition is described that contains high levels of Petrolatum and shows a substantial decrease in reflectance compared with isotropic cleansing compositions containing other oils and liquid crystalline compositions with similar levels of oils. The inventive composition has a total of less than 2% by wt. of other oils such as glyceride, mineral and silicone oils, or blends thereof. | 2016-03-10 |
20160067155 | FOAMABLE COSMETIC PRODUCT - Provided is a cosmetic product which can generate a carbon dioxide gas to cause foaming by a simple method and having excellent usability. Provided is a cosmetic product comprising a first composition and a second composition different from the first composition as constituent elements of the cosmetic product and which foams by mixing the first composition and the second composition, wherein the first composition is a liquid or creamy composition containing a bicarbonate and/or a carbonate, and the second composition is a liquid or creamy composition containing an α-hydroxy acid and/or a saturated dibasic acid in which the content of water is 1.0-fold or less in terms of weight ratio with respect to the α-hydroxy acid and/or the saturated dibasic acid. | 2016-03-10 |
20160067156 | TOOTHPASTE DROPLETS - A droplet for delivering toothpaste to a user can be provided. The droplet can include a dissolvable outer membrane defining a volume with toothpaste inside the volume. The outer membrane can be formed from dissolvable film strip technology and include a tail or corner portion, which is configured to be embedded into the bristles of a toothbrush. In one aspect of this embodiment, the outer membrane of the droplet can form a pillow-like shape. The droplet further can include one or more extensions coupled to the outer surface of the outer membrane, where the one or more extensions can have a triangular shape, a barb shape or the like. In one aspect of this embodiment, the droplet further can include a logo, a cartoon character, a word or the like printed on the outer membrane. The plurality of extensions can form irregularities on the outer surface of the body section of the outer membrane. | 2016-03-10 |
20160067157 | Cosmetic Composition Containing Novel Fractal Particle-Based Gels - A method of instantly reducing the appearance of wrinkles and skin imperfections while smoothing the skin, which comprises applying a cosmetic composition comprising a fractal particle based gel. | 2016-03-10 |
20160067158 | AGENTS CONTAINING LARGE QUANTITIES OF UV STABILIZERS - The invention relates to highly concentrated agents for the preparation of sunscreen final formulations, comprising
| 2016-03-10 |
20160067159 | ANTIMICROBIAL SOAPS CONTAINING CARVACROL AND METHODS OF USING SAME - The present invention relates to antimicrobial formulations containing carvacrol and at least one of the following 2-phenoxyethanol, caprylyl glycol and hexylene glycol. | 2016-03-10 |
20160067160 | USE OF A 2-METHYLSUCCINIC ACID DIESTER DERIVATIVE AS SOLVENT IN COSMETIC COMPOSITIONS; COSMETIC COMPOSITIONS CONTAINING THE SAME - The present invention relates to the use of at least one 2-methylsuccinic acid diester derivative of formula (I) below: | 2016-03-10 |
20160067161 | COSMETIC OR PHARMACEUTICAL COMPOSITION FOR RESISTING SKIN AGEING THROUGH AN ANTI-INFLAMMATORY ACTION - The invention relates to the use of compounds of formula (I) R—N | 2016-03-10 |
20160067162 | PHOTOPROTECTIVE COMPOUNDS, COMPOSITIONS INCLUDING SAME AND USES THEREOF - A compound of formula (I): | 2016-03-10 |
20160067163 | A Composition for Lightening Skin and Hair - Suggested is a composition comprising (a) sclareolide and (b1) at least one tyrosinase inhibitor; and/or (b2) at least one sun protection factor; and/or (b3) at least one anti-oxidants; and/or (b4) at least one anti-inflammatory agent; and/or (b5) at least one desquamating agent, on condition that compound a is present in an amount of from 0.00001 to 0.001% b.w.—calculated on the total composition. | 2016-03-10 |
20160067164 | NAIL COATINGS HAVING ENHANCED ADHESION - Adhesion of a composition for nail coatings be improved by addition of a polyhedral oligomeric silsesquioxane (POSS). Nail coating compositions that benefit from the addition of a POSS include enamels, reactive composition such as those containing acrylates, solventless compositions and water-based compositions. | 2016-03-10 |
20160067165 | METHODS FOR LIGHTENING SKIN USING ARBUTIN COMPOSITIONS - Arbutin-containing compositions are useful for topical application to provide enhanced luminosity, brightening or lightening to the skin of a user and are at least 85% as efficacious (with regard to skin lightening, when used alone or in a system as measured by Chromameter® b* parameter values) as substantially corresponding compositions containing hydroquinone in an mount from about the same molar amount to about 1.5 times the molar amount of arbutin. | 2016-03-10 |
20160067166 | COSMETIC COMPOSITION COMPRISING A NATURAL ORGANIC OIL AND POLYMETHYLMETHACRYLATE PARTICLES - The present invention relates to a topical composition comprising a natural organic oil and a porous cross-linked polymethylmethacrylate bead having a particle size D | 2016-03-10 |
20160067167 | ORAL CARE COMPOSITIONS FOR TREATMENT OF SENSITIVE TEETH - The present invention provides oral care compositions for treating tooth sensitivity. The composition comprises a synergistic mixture containing a copolymer having at least one repeating unit of alkyl vinyl ether functionality and a monomer having at least one repeating unit of ethylenically unsaturated dicarboxylic acid or anhydride functionality present in an amount of about 0.1 to about 50% (w/w) of the total mixture; and a homo polymer having repeating unit of alkyl vinyl ether functionality present in an amount of about 0.1 to about 50% (w/w) of the total mixture. These synergistic mixtures of polymers act as barriers for dentin flow and reduce pain and discomfort caused by tooth sensitivity and exhibits at least 60% average reduction in dentin flow. | 2016-03-10 |
20160067168 | ORAL AND DENTAL HYGIENE AND CLEANING AGENTS FOR SENSITIVE TEETH - The invention relates to oral and dental hygiene and cleaning agents which contain, in relation to their weight, between 0.001 and 25% by weight polylactic acid particles and between 1 and 30% by weight precipitated silicic acid(s) with a specific surface area according to ISO 5794-1, Appendix D, of ≦60 m | 2016-03-10 |
20160067169 | TOOTHPASTE CONTAINING FLUORIDE AND POLYLACTIC ACID PARTICLES - Oral and dental hygiene and cleaning agents, which contain, relative to the weight thereof, 0.001 to 25 wt % polylactic acid particles and 1200 to 1600 ppm fluoride have a substantially improved degree of fluoride deposition and offer an optimum compromise between applicability and plaque reduction. | 2016-03-10 |
20160067170 | ORAL AND DENTAL HYGIENE AND CLEANING AGENTS WITH IMPROVED ANTI-BACTERIAL ACTION - The anti-inflammatory and preventive action of antimicrobial substances can surprisingly be enhanced by the use of polylactic acid particles. Corresponding advantageous products are in particular oral and dental care and cleaning products that—based on the weight thereof—comprise 0.001 to 25 wt. % polylactic acid particles and 0.00001 to 5 wt. % of at least one antibacterial compound from the groups consisting of the benzoates and/or the parabens and/or the Cu salts and/or the Ag salts and/or triclosan and/or hexetidine. | 2016-03-10 |
20160067171 | ORAL AND DENTAL HYGIENE AND CLEANING AGENTS WITH OPTIMIZED TASTE - The invention relates to oral and dental hygiene- and cleaning agents having an improved taste and a “silky sensation” in the mouth, said agents containing, in relation to their weight, between 0.001 and 25 wt. % poly(lactic acid) particles, between 0 and 15 wt. % sorbitol and between 0 and 30 wt. % glycerol, with the proviso that the total quantity of ingredient(s) in groups b) and c) lies between 5 and 40 wt. %. | 2016-03-10 |
20160067172 | Sulfate-Free Personal Care Compositions and Methods - A personal care composition includes a surfactant; and a polymer comprising a hydrophobically modified polyurethane, a hydrophobically modified polyether polyol, or a combination thereof; wherein the personal care composition has a viscosity ranging from about 8,000 cP to about 40,000 cP; and wherein the personal care composition is free of sulfates | 2016-03-10 |
20160067173 | COSMETIC USE OF A GERANIOL-RICH ESSENTIAL OIL OF SATUREJA MONTANA AS DEODORANT ACTIVE AGENT - The present invention relates to the cosmetic use, as deodorant active agent, of an essential oil of | 2016-03-10 |
20160067174 | PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES USING SYSTEMS AND METHODS FOR TRANSDERMAL NITRIC OXIDE DELIVERY - The present invention generally relates to compositions and methods for treatment of subjects having or at risk of arteriosclerosis, hypertension, sickle-cell anemia, or other conditions. In some cases, the composition may include nitric oxide. The nitric oxide may be present within a first phase comprising a lecithin, such as phosphatidylcholine. In certain embodiments, the lecithin is present in liposomes, micelles, or other vesicles containing nitric oxide. The composition can take the form of a gel, a cream, a lotion, an ointment, a solution, a solid “stick,” etc., that can be rubbed or sprayed onto the skin, e.g., onto a location with acne, or on another suitable portion of the skin. Other aspects of the present invention are generally directed to methods of making or using such compositions, methods of promoting such compositions, kits including such compositions, or the like. | 2016-03-10 |
20160067175 | INTRATHECAL MULTIDRUG INFUSION FOR PAIN CONTROL - The present invention relates to an intrathecal (IT) formulation comprising an opioid, a Na channel blocker, an alpha2-receptor agonist, an opioid mu or delta receptor competitive antagonist and an intravenous anesthetic. | 2016-03-10 |
20160067176 | MICROSTRUCTURE ARRAY, METHODS OF MAKING, AND METHODS OF USE - A microprojection array comprising an approximately planar base and a plurality of microprojections, wherein the array comprises a therapeutic agent that is poorly soluble in water or an aqueous solvent. | 2016-03-10 |
20160067177 | PROCESS FOR MAKING CONTROLLED RELEASE MEDICAL IMPLANT PRODUCTS - A method (and the resulting product) of making a medical implant device for releasing self-contained drugs on a controlled basis wherein the method utilizes, at least in part, computer-controlled 3-D printing equipment to deposit via nozzles portions of one or more layers of the medical implant product. The implant has an outer impervious coating, an inner matrix core, an opening and an optional bonding layer. | 2016-03-10 |
20160067178 | METHODS FOR MANUFACTURING IMPLANTS - Pharmacologically active implants, in particular subcutaneous implants, intrauterine devices, and intravaginal rings, are provided herein. Methods for forming an active ingredient-containing core are described. Methods for laminating an active ingredient-containing core to form a rate-controlling sheath are also described. | 2016-03-10 |
20160067179 | CONTROLLED RELEASE ANTIMICROBIAL COMPOSITIONS AND METHODS FOR THE TREATMENT OF OTIC DISORDERS - Disclosed herein are compositions and methods for the treatment of otic diseases or conditions with antimicrobial agent compositions and formulations administered locally to an individual afflicted with an otic disease or condition, through direct application of these compositions and formulations onto or via perfusion into the targeted auris structure(s). | 2016-03-10 |
20160067180 | SEMI-SOLID CHEWABLE DOSAGE FORM FOR OVER-THE-COUNTER MEDICATIONS AND METHOD FOR PRODUCING SAME - The invention provides a semi-solid chewable dosage form for use as an over-the-counter medication that contains an active pharmaceutical ingredient to treat symptoms associated with allergies, colds, coughs, fever, pain, gastrointestinal disorders, sleep, and other common conditions. The invention further provides a semi-solid chewable dosage form that contains an active pharmaceutical ingredient, a gelling agent, gelatin, sugar, a polyol, and a pH adjusting agent. The invention also provides a semi-solid chewable dosage form that contains a gelling agent, sugar, a polyol, glycerin, and a pH adjusting agent. | 2016-03-10 |
20160067181 | TWO-LAYER SEPARATION-TYPE EYE DROP CONTAINING SQUALANE - The purpose of the present invention is to provide a technique for formulating a two-layer separation-type ophthalmic solution in which, during storage, an aqueous layer and an oil-containing layer containing squalane are separated from each other, wherein it is possible to homogeneously disperse the oil-containing layer in the aqueous layer while suppressing foaming by shaking the ophthalmic solution before administration, and the homogeneous dispersed state is maintained in a stable manner at least until administration. A two-layer separation-type ophthalmic solution containing squalane and water, wherein hyaluronic acid and/or a salt thereof and polyvinyl alcohol are contained in the ophthalmic solution and the polyvinyl alcohol content is set to 0.025 to 0.1 w/v %, whereby it is possible to homogeneously disperse the oil-containing layer in the aqueous layer while suppressing foaming by shaking the ophthalmic solution before administration, and to maintain the homogeneous dispersed state in a stable manner at least until administration. | 2016-03-10 |
20160067182 | METHODS AND COMPOSITIONS FOR IMPROVING OUTCOMES OF LIPOSOMAL CHEMOTHERAPY - Materials and methods for treating cancer patients with immunoliposomal chemotherapeutic agents are disclosed. The methods comprise administering to a patient a therapeutically effective amount of an immunoliposome in combination with a chemotherapeutic agent comprising an alkylating agent or an organoplatinum agent. The materials are immunoliposomal chemotherapeutic agents and chemotherapeutic preparations comprising an alkylating agent or an organoplatinum agent, each for use in the disclosed methods. | 2016-03-10 |
20160067183 | SUBSTITUTED DIKETOPIPERAZINE ANALOGS FOR USE AS DRUG DELIVERY AGENTS - Disclosed are drug delivery systems for the delivery of small molecule and macromolecular drugs. More particularly, disclosed are substituted analogs of 3,6-di(alkyl-4 aminobutyl)-2,5-diketopiperazine (which may also be referred to DKP), their use in the formulation of both small molecule and macromolecular drugs including therapeutic, prophylactic and diagnostic agents, stabilizing agents and systems for their delivery. | 2016-03-10 |
20160067184 | Oral Dosing of GLP-1 Compounds - The present invention relates to improved uses of GLP-1 peptides in oral therapy. | 2016-03-10 |
20160067185 | SOLID PHARMACEUTICAL COMPOSITION - [Problem] To provide a solid pharmaceutical composition which contains a compound represented by general formula (1) or a salt thereof and suppresses decomposition of said compound or salt thereof, and a production method of said solid pharmaceutical composition. [Solution] This solid pharmaceutical composition contains a compound represented by general formula (1) or a salt thereof, a cellulosic excipient, and an acidic substance of pH 4.0 or less. | 2016-03-10 |
20160067186 | Controlled-Release Melatonin Compositions and Related Methods - A method of treating a human subject in need of melatonin therapy includes administering to a human subject a compressed tablet comprising melatonin, citric acid, and a cellulosic polymer. The melatonin, citric acid, and cellulosic polymer combine after ingestion to form an acidic hydrogel that dissolves the melatonin and is effective to provide a first release dose of melatonin for assisting in inducement of sleep and a subsequent sustained release dose of melatonin for assisting in sustaining sleep while in the human subject's gastrointestinal tract. | 2016-03-10 |
20160067187 | Methods for Treating or Preventing Migraines - The present invention provides a method for treating or preventing one or more types of migraines by administering a monoamine oxidase inhibitor, preferably Isocarboxazid, to a patient without invoking hypertensive crisis. | 2016-03-10 |
20160067188 | HYDROXYPROPYL METHYL CELLULOSE HARD CAPSULES AND PROCESS OF MANUFACTURE - A composition for manufacture of hard hydroxypropyl methyl cellulose capsules comprising a film forming material of hydroxypropyl methyl cellulose having a methoxy content of 27.0-30.0% (w/w), and a hydroxypropoxy content of 4.0-7.5% and as a 2% weight solution, a viscosity of 3.5-6.0 cPs at 20° C., dipping compositions, process for manufacture of hard hydroxypropyl methyl cellulose capsules according to a dip coating process and hard capsule shells. | 2016-03-10 |
20160067189 | ORAL PHARMACEUTICAL COMPOSITION COMPRISING TASTE-MASKED N-ACETYLCYSTEINE - The invention provides coated particles with taste-masked N-acetylcysteine. The particles comprise a core with the active ingredient and a coating comprising a triglyceride and a surfactant. The particles exhibit rapid drug release and a stable release profile. Moreover, the invention provides a hot-melt coating method for manufacturing such particles, and pharmaceutical compositions comprising the particles. The method allows the coating of core particles at moderate temperatures, thereby preventing the degradation of the thermolabile active ingredient. | 2016-03-10 |
20160067190 | INJECTABLE NANO-NETWORK GELS FOR DIABETES TREATMENT - A system for “smart” delivery of a therapeutic, prophylactic or diagnostic agent, such as glucose-mediated delivery of insulin through an injectable nano-network consisting of oppositely-charged dextran nanoparticles encapsulating insulin and glucose-specific enzymes forming a gel-like 3D scaffold. As demonstrated by the examples, the system effectively dissociates to release insulin in a hyperglycemic condition, where the catalytic conversion of glucose into gluconic acid and the subsequent degradation of polymeric matrix are facilitated. This formulation design provides a delivery strategy for both self-regulated and long-term diabetes management. | 2016-03-10 |
20160067191 | NANOSCALE COATINGS FOR ENCAPSULATION OF BIOLOGICAL ENTITIES - Methods, systems, and devices are disclosed for encapsulating biological entities with preservation of their biological activity. In one aspect, a method of encapsulating a biological entity includes templating a biocompatible material onto a biological structure to form a coating structure enclosing the biological structure, the coating structure having a size in the nanometer range, in which the coated biological structure preserves its biological activity within the coating structure. In some implementations of the method, the biological structure includes a virus and the biocompatible material includes silica. | 2016-03-10 |
20160067192 | Anxiolytic Effect of Pterostilbene - We report for the first time that pterostilbene, a natural analog of resveratrol, shows anxiolytic-like action by downregulating phosphorylated levels of ERKs in the hippocampus of mice. Mice administered pterostilbene (1-10 mg/kg BW) by oral gavage were subjected to the Elevated-plus maze (EPM) test. Pterostilbene manifested anxiolytic activity at 1 and 2 mg/kg doses, demonstrated by an increase in percent permanence time and number of entries in open arms, critical determinants correlated with anxiety. This anxiolytic activity of pterostilbene was comparable to that of diazepam at 1 and 2 mg/kg in the EPM. The percent traveled distance and the percent permanence time in the enclosed arms were decreased with the 1 and 2 mg/kg doses. The 5 and 10 mg/kg doses did not show any anxiolytic effect. Locomotor activity was unaffected in all doses. Western blot analysis corroborated the observed behaviors in the EPM, revealing a decrease in both ERK1 and ERK2 phosphorylation in hippocampal homogenates from mice treated with 1 and 2 mg/kg doses; the 5 and 10 mg/kg doses showed no significant effect on the phosphorylation of ERKs. Pterostilbene was detected in serum and brain tissue following a single oral administration, demonstrating that the compound can cross the blood-brain barrier to reach the brain regions, including hippocampus, and thereby exert its anxiolytic effect. Resveratrol, the parent molecule of pterostilbene, did not have any anxiolytic effect. | 2016-03-10 |
20160067193 | TOPICAL PTEROSTILBENE COMPOSITIONS FOR USE IN TREATING UV-INDUCED SKIN DAMAGE AND HYPERPLASIA - A chemoprotective method for treating, inhibiting or preventing DNA damage in skin and/or hyperplasia caused by ultraviolet (UV) light by using an effective amount of pterostilbene is provided. Pharmaceutical and nutraceutical compositions containing pterostilbene suitable for administration to an individual in order to prevent subsequent UV-mediated DNA damage and/or hyperplasia in skin are provided. | 2016-03-10 |
20160067194 | TOPICAL PTEROSTILBENE COMPOSITIONS FOR USE IN TREATING UV-INDUCED LOSS OF BARRIER FUNCTION IN SKIN - A chemoprotective method for treating, inhibiting or preventing loss of barrier function in skin caused by ultraviolet (UV) light by using an effective amount of pterostilbene is provided. Pharmaceutical and nutraceutical compositions containing pterostilbene suitable for administration to an individual in order to prevent subsequent UV-mediated loss of barrier function in skin are provided. | 2016-03-10 |
20160067195 | METHOD FOR TESTING RISK OF MULTIPLE SYSTEM ATROPHY, TEST KIT, AND DRUG FOR THE TREATMENT OR PREVENTION OF MULTIPLE SYSTEM ATROPHY - An object of the present invention is to elucidate the onset mechanism of MSA through specification of a causative gene of it and further, to find a treatment method of it. The present invention provides a method for testing a multiple system atrophy risk of a test subject including a step of detecting a variant that deteriorates the biosynthesis of coenzyme Q10 in a sample collected from the test subject. Examples of the variant that deteriorates the biosynthesis of coenzyme Q10 include variants that suppress the expression or function of coenzyme Q2. | 2016-03-10 |
20160067196 | METHOD FOR TREATING POST-TRAUMATIC STRESS DISORDER - The present disclosure provides compositions containing ketamine and methods of using those compositions for the treatment of post-traumatic stress disorder. Also provided herein is a pharmaceutical composition that comprises esketamine and a pharmaceutically acceptable carrier, excipient or diluent, for use in treatment of PTSD. In some aspects, the pharmaceutical composition is for intranasal or intravenous administration. In some aspects, the pharmaceutical composition is for use in a method of treating PTSD in a subject. In some aspects, the pharmaceutical composition is for use in a method of treating major depressive disorder in a subject that is co-morbid with the PTSD. | 2016-03-10 |
20160067197 | TOPICAL COMPOSITIONS AND METHODS FOR MAKING AND USING SAME - The present invention relates to improved topical gel compositions comprising an active agent, and uses thereof. | 2016-03-10 |
20160067198 | HALOGENATED ALIPHATIC CARBOXYLIC ACIDS, OLIGOMERS AND/OR POLYMERS THEREOF AND THEIR USE IN DEVITALIZING EXTERNAL AND INTERNAL NEOPLASMS - Halogenated aliphatic carboxylic acids, salts and/or oligomers or polymers thereof, which exhibit a devitalizing effect of neoplastic tissues, are disclosed. Methods and uses that utilize these compounds for the treatment of medical conditions associated with a neoplastic tissue are also disclosed. Further disclosed are methods and uses that utilize these compounds for reducing or abolishing blood and lymph as well local dissemination of malignant neoplastic cells during a surgical removal thereof, thereby preventing recurrences and distance metastases, and/or inducing immune response to potentially malignant, pre-malignant and/or malignant cells. Further disclosed are novel oligomeric forms of halogenated aliphatic carboxylic acids, pharmaceutical compositions containing same and uses thereof. | 2016-03-10 |
20160067199 | NOVEL FORMULATION OF DICLOFENAC - The present invention relates to methods for producing particles of diclofenac using dry milling processes as well as compositions comprising diclofenac, medicaments produced using diclofenac in particulate form and/or compositions, and to methods of treatment of an animal, including man, using a therapeutically effective amount of diclofenac administered by way of said medicaments. | 2016-03-10 |
20160067200 | USES OF 6-AMINOHEXANOIC ACID TO MANAGE BLEEDING CONDITIONS - This disclosure relates to the use of EACA (6-aminohexanoic acid) as an antifibrinolytic for the prevention of thrombocytopenic bleeds. In certain embodiment, the disclosure relates to methods of preventing bleeding in patients with thrombocytopenia resulting from hematological malignancies by administering 6-aminohexanoic acid, salts, or prodrugs thereof prophylactically to a subject in need thereof. In certain embodiments, subjects with stable chronic thrombocytopenia previously managed with platelet transfusion represent a selected group of patients that benefit from prophylaxis. | 2016-03-10 |
20160067201 | COMPOSITIONS AND METHODS FOR THE REDUCTION OR PREVENTION OF HEPATIC STEATOSIS - Methods useful for reducing or preventing non-alcoholic steatohepatitis or hepatic steatosis are provided herein. Such methods may comprise administering to a subject in need thereof a sirtuin pathway activator and/or PDE5 inhibitor alone or in combination with an amount of a branched amino acid in free amino acid form, or a metabolite thereof. Also provided herein are compositions and kits for practicing any of the methods described herein. | 2016-03-10 |